New hope for frail AML patients: less toxic drug combo shows promise
Disease control
Completed
This study tests a new drug combination using selinexor with fewer or no harsh chemo drugs for adults newly diagnosed with acute myeloid leukemia (AML) who are too frail for standard intensive chemo. The goal is to quickly reduce leukemia cells while causing fewer side effects. A…
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC